2012-06-15 08:56:17 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Orthostatic Hypotension - Pipeline Review, H1 2012', provides an overview of the Orthostatic Hypotension therapeutic pipeline. This report provides information on the therapeutic development for Orthostatic Hypotension , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Orthostatic Hypotension . 'Orthostatic Hypotension - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/398715_orthostatic_hypotension_pipeline_revi ..


Note*: Certain sections in the report may be

removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Orthostatic Hypotension .
* A review of the Orthostatic Hypotension products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Orthostatic Hypotension pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Orthostatic Hypotension .
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Orthostatic Hypotension pipeline depth and focus of Orthostatic Hypotension therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Orthostatic Hypotension Therapeutic Products under Development, Key Players in Orthostatic Hypotension Therapeutics, Orthostatic Hypotension Pipeline Overview, Orthostatic Hypotension Pipeline, Orthostatic Hypotension Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Orthostatic Hypotension Overview
Therapeutics Development
An Overview of Pipeline Products for Orthostatic Hypotension
Orthostatic Hypotension Therapeutics under Development by Companies
Orthostatic Hypotension Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Orthostatic Hypotension Therapeutics - Products under Development by Companies
Orthostatic Hypotension Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Orthostatic Hypotension Therapeutics Development
Chelsea Therapeutics, Inc.
Orthostatic Hypotension - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Northera - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Droxidopa + Alpha-methyldopa + Carbidopa + Metyrosine + Levodopa + Atomoxetine + Metoclopramide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Midodrine Hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acetazolamide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Orthostatic Hypotension Therapeutics - Drug Profile Updates
Orthostatic Hypotension Therapeutics - Dormant Products
Orthostatic Hypotension - Product Development Milestones
Featured News & Press Releases
Apr 27, 2012: Chelsea To Present Results From Pivotal Northera Study At AAN Annual Meeting
Mar 29, 2012: Shire Reports FDA's Update On Midodrine HCl
Mar 28, 2012: Chelsea Receives Complete Response Letter From FDA For Northera Capsules
Feb 23, 2012: FDA Advisory Panel Recommends Approval Of Chelsea's NORTHERA To Treat Neurogenic Orthostatic Hypotension
Feb 21, 2012: Chelsea To Discuss NORTHERA NDA For Treatment Of Neurogenic Orthostatic Hypotension At FDA Advisory Committee Meeting
Feb 13, 2012: Chelsea Therapeutics's CEO To Review NORTHERA NDA And Provide Update On Upcoming Advisory Committee Meeting During Presentation At BIO CEO

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=398715&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.